A Possible Solution To Europe's Pharma Financing Problem
Recession and consequent cuts in public pharmaceutical expenditure in Europe have slowed down the access to market of pharmaceutical innovations in the last few years. As a solution, public health authorities...To view the full article, register now.
Already a subscriber? Click here to view full article